LIGHT/TNFSF14 as a New Biomarker of Bone Disease in Multiple Myeloma Patients Experiencing Therapeutic Regimens-Reference-Cited by-同舟云学术

LIGHT/TNFSF14 as a New Biomarker of Bone Disease in Multiple Myeloma Patients Experiencing Therapeutic Regimens

Published:2018-10-23 Issue: Volume:9 Page:
ISSN:1664-3224
Container-title:Frontiers in Immunology
language:
Short-container-title:Front. Immunol.

Author:

Brunetti Giacomina,Rizzi Rita,Storlino Giuseppina,Bortolotti Sara,Colaianni Graziana,Sanesi Lorenzo,Lippo Luciana,Faienza Maria Felicia,Mestice Anna,Curci Paola,Specchia Giorgina,Grano Maria,Colucci Silvia

Publisher

Frontiers Media SA

Subject

Immunology,Immunology and Allergy

Reference37 articles.

1. Current use of monoclonal antibodies in the treatment of multiple myeloma;Varga;Br J Haematol,2018

2. Pathogenesis of bone disease in multiple myeloma: from bench to bedside;Terpos;Blood Cancer J,2018

3. Multiple myeloma;Palumbo;N Engl J Med,2011

4. Emerging roles of osteoclasts in the modulation of bone microenvironment and immune suppression in multiple myeloma;Mansour;Front Immunol,2017

5. Pathogenesis of myeloma bone disease;Roodman;Leukemia,2009

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. LIGHT protein: A novel gingival crevicular fluid biomarker associated with increased probing depth after periodontal surgery;Journal of Clinical Periodontology;2024-02-23

2. High levels of LIGHT/TNFSF14 in patients with Prader–Willi syndrome;Journal of Endocrinological Investigation;2023-03-14

3. Myeloma bone disease: pathogenesis and management in the era of new anti-myeloma agents;Journal of Bone and Mineral Metabolism;2023-03-01

4. Elevated Levels of the Cytokine LIGHT in Pediatric Crohn’s Disease;The Journal of Immunology;2023-01-23

5. Antibody Treatment and Osteoporosis: Clinical Perspective;Springer Series in Biomaterials Science and Engineering;2022